• A Novel Co-existence of Spinocerebellar Ataxia 1 and Spinocerebellar Ataxia 2 Mutations in Indian Patients
• A rehabilitation program to increase balance and mobility in ataxia of Charlevoix-Saguenay: An exploratory study
• Abnormal scaffold attachment factor 1 expression and localization in spinocerebellar ataxias and Huntington's chorea
• Accidental Falls in Patients with Hyperkinetic Movement Disorders: A Systematic Review
• Altered cerebral blood flow in patients with spinocerebellar degeneration
• Ameliorating effect of rovatirelin on the ataxia in rolling mouse Nagoya
• Antisense Transcription across Nucleotide Repeat Expansions in Neurodegenerative and Neuromuscular Diseases: Progress and Mysteries
• Association of serum neurofilament light and disease severity in patients with spinocerebellar ataxia type 3
• Association of SLC22A1 rs622342 and ATM rs11212617 polymorphisms with metformin efficacy in patients with type 2 diabetes
• Ataxic Severity Is Positively Correlated With Fatigue in Spinocerebellar Ataxia Type 3 Patients
• Autosomal recessive spinocerebellar ataxia SCAR8/ARCA1: first families detected in Spain
• Between responsibility and desire: Accounts of reproductive decisions from those at risk for or affected by late-onset neurological diseases
• Brain MRI Volumetry Analysis in an Indonesian Family of SCA 3 Patients: A Case-Based Study
• Brain structural abnormalities in the preclinical stage of Machado-Joseph disease/spinocerebellar ataxia type 3 (MJD/SCA3): evaluation by MRI morphometry, diffusion tensor imaging and neurite orientation dispersion and density imaging
• CAG Repeat Size Influences the Progression Rate of Spinocerebellar Ataxia Type 3
• Cannabis use in patients with Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay
• Case Report: Deep brain stimulation improves tremor in <em>FGF-14</em> associated spinocerebellar ataxia
• CerebNet: A fast and reliable deep-learning pipeline for detailed cerebellum sub-segmentation
• Clinical and Molecular Spectrum of Degenerative Cerebellar Ataxia: A Single Centre Study
• Clinical features and genetic characteristics of homozygous spinocerebellar ataxia type 3
• Co-existence of spastic paraplegia-30 with novel KIF1A mutation and spinocerebellar ataxia 31 with intronic expansion of BEAN and TK2 in a family
• Cognitive Decline Is Closely Associated with Ataxia Severity in Spinocerebellar Ataxia Type 2: a Validation Study of the Schmahmann Syndrome Scale
• Cognitive impairment and its neuroimaging correlates in spinocerebellar ataxia 2
• Cognitive impairment in spinocerebellar ataxia type 12
• Collaborative Efforts for Spinocerebellar Ataxia Research in the United States: CRC-SCA and READISCA
• Composite autonomic severity scoring in spinocerebellar ataxia type 1 and 2
• Conservative Iron Chelation for Neuroferritinopathy
• Corticospinal tract involvement in spinocerebellar ataxia type 3: a diffusion tensor imaging study
• Development and validation of an ultrahigh-performance liquid chromatography-tandem mass spectrometry method to investigate the plasma pharmacokinetics of a K_Ca 2.2/K_Ca 2.3 positive allosteric modulator in mic
• Digenic inheritance of STUB1 variants and TBP polyglutamine expansions explains the incomplete penetrance of SCA17 and SCA48
• Disability in cerebellar ataxia syndromes is linked to cortical degeneration
• Diverse species-specific phenotypic consequences of loss of function sorting nexin 14 mutations
• Effects of Repetitive Transcranial Magnetic Stimulation on Cerebellar Metabolism in Patients With Spinocerebellar Ataxia Type 3
• Effects of the administration of Elovl5-dependent fatty acids on a spino-cerebellar ataxia 38 mouse model
• Eip74EF is a dominant modifier for ALS-FTD-linked VCP^R152H phenotypes in the Drosophila eye model
• Evidence and practices of the use of next generation sequencing in patients with undiagnosed autosomal dominant cerebellar ataxias: a review
• Expanded CAG Repeats in ATXN1, ATXN2, ATXN3, and HTT in the 1000 Genomes Project
• Extreme phenotypic heterogeneity in non-expansion spinocerebellar ataxias
• Familial Cerebellar Ataxia and Amyotrophic Lateral Sclerosis/Frontotemporal Dementia with DAB1 and C9ORF72 Repeat Expansions: An 18-Year Study
• Family history as a clue to the diagnosis of orofacial abnormal movements in a 30-year-old man
• Gait training with a wearable curara® robot for cerebellar ataxia: a single-arm study
• Gait training with a wearable powered robot during stroke rehabilitation: a randomized parallel-group trial
• Genetic analysis of a child with Charlevoix-Saguenay spastic ataxia due to variant of SACS gene
• Genetic Dominant Variants in <em>STUB1,</em> Segregating in Families with SCA48, Display In Vitro Functional Impairments Indistinctive from Recessive Variants Associated with SCAR16
• Genome sequencing identifies rare tandem repeat expansions and copy number variants in Lennox-Gastaut syndrome
• GM2 gangliosidosis AB variant: first case of late onset and review of the literature
• Hsa-miR223-3p circulating level is upregulated in Friedreich's ataxia and inversely associated with HCLS1 associated protein X-1, HAX-1
• Inherited Cerebellar Ataxias: 5-Year Experience of the Irish National Ataxia Clinic
• Intrafamilial phenotypic variation in spinocerebellar ataxia type 23
• Investigation on the growth factor regulatory network of dermal fibroblasts in mouse full-thickness skin defect wounds based on single-cell RNA sequencing
• Liver Assessment in Patients with Ataxia-Telangiectasia: Transient Elastography Detects Early Stages of Steatosis and Fibrosis
• Long-term efficacy of bilateral subthalamic deep brain stimulation in the parkinsonism of SCA 3: A rare case report
• Low Prevalence of NOTCH2NLC GGC Repeat Expansion in White Patients with Movement Disorders
• Magnetic Resonance Imaging and Its Clinical Correlation in Spinocerebellar Ataxia Type 3: A Systematic Review
• Milestones in genetics of cerebellar ataxias
• Minigene-based splicing analysis and ACMG/AMP-based tentative classification of 56 ATM variants
• Mycoplasma DnaK increases DNA copy number variants in vivo
• Neuro-Ophthalmological Findings in Friedreich's Ataxia
• Neurocutaneous Syndromes, Perinatal Factors, and the Risk of Childhood Cancer in Sweden
• Neurofilament Light Chain Is a Biomarker of Neurodegeneration in Ataxia Telangiectasia
• Non-motor symptoms in patients with autosomal dominant spinocerebellar ataxia
• Novel Genetic Variant of Ataxia Telangiectasia Presenting with Necrotising Pneumonia and Bronchopleural Fistulae at the Age of 4 Years
• Novel mutation in a patient with Charlevoix-Saguenay ataxia-a very rare disease with classical symptoms
• Novel mutation in exon11 of <em>PRKCG</em> (SCA14): A case report
• Ovarian and uterine carcinosarcomas are sensitive in vitro and in vivo to elimusertib, a novel ataxia-telangiectasia and Rad3-related (ATR) kinase inhibitor
• Parkinsonism in spinocerebellar ataxia with axonal neuropathy caused by adult-onset COA7 variants: a case report
• Pathogenic mechanisms underlying spinocerebellar ataxia type 1
• Phase I trial of ATM inhibitor M3541 in combination with palliative radiotherapy in patients with solid tumors
• Possibilities and challenges of small molecule organic compounds for the treatment of repeat diseases
• Progress of macular atrophy during 30 months' follow-up in a patient with spinocerebellar ataxia type1 (SCA1)
• Quantitation of the ataxia-telangiectasia-mutated and Rad3-related inhibitor elimusertib (BAY-1895344) in human plasma using LC-MS/MS
• Radiation-induced DNA damage and repair effects on 3D genome organization
• Real-Life Turning Movements Capture Subtle Longitudinal and Preataxic Changes in Cerebellar Ataxia
• Redox Imbalance Associates with Clinical Worsening in Spinocerebellar Ataxia Type 2
• Rovatirelin ameliorates motor dysfunction in the cytosine arabinoside-induced rat model of spinocerebellar degeneration via acetylcholine and dopamine neurotransmission
• RP-3500: A Novel, Potent, and Selective ATR Inhibitor that is Effective in Preclinical Models as a Monotherapy and in Combination with PARP Inhibitors
• Scale for the assessment and rating of ataxia: Age-dependent performance of healthy adults
• Short-term efficacy of repetitive transcranial magnetic stimulation in SCA3: A prospective, randomized, double-blind, sham-controlled study
• Simultaneous ALS and SCA2 associated with an intermediate-length <em>ATXN2</em> CAG-repeat expansion
• Small Molecule Rescue of ATXN3 Toxicity in C. elegans via TFEB/HLH-30
• Spinocerebellar Ataxia 12 Patients have better Quality of Life than Spinocerebellar Ataxia 1 and 2
• Spinocerebellar Ataxia Type 1 protein Ataxin-1 is signaled to DNA damage by ataxia-telangiectasia mutated kinase
• Spinocerebellar Ataxia Type 1: One-Year Longitudinal Study to Identify Clinical and MRI Measures of Disease Progression in Patients and Presymptomatic Carriers
• Spinocerebellar ataxia type 15 caused by missense variants in the ITPR1 gene
• Targeting mGlu1 Receptors in the Treatment of Motor and Cognitive Dysfunctions in Mice Modeling Type 1 Spinocerebellar Ataxia
• The ARCA Registry: A Collaborative Global Platform for Advancing Trial Readiness in Autosomal Recessive Cerebellar Ataxias
• The CCAS-scale in hereditary ataxias: helpful on the group level, particularly in SCA3, but limited in individual patients
• The Complex Genetic Landscape of Hereditary Ataxias in Turkey and Implications in Clinical Practice
• The genetic spectrum of a cohort of patients clinically diagnosed as Parkinson's disease in mainland China
• The longitudinal progression of MRI changes in pre-ataxic carriers of SCA3/MJD
• The Natural History of Spinocerebellar Ataxia Type 3 in Mainland China: A 2-Year Cohort Study
• The reliability of gait parameters captured via instrumented walkways: a systematic review and meta-analysis
• The S-Factor, a New Measure of Disease Severity in Spinocerebellar Ataxia: Findings and Implications
• Toxicity of pathogenic ataxin-2 in Drosophila shows dependence on a pure CAG repeat sequence
• Trehalose in Machado-Joseph Disease: Safety, Tolerability, and Efficacy
• Trinucleotide Repeat Disorders
• ULK overexpression mitigates motor deficits and neuropathology in mouse models of Machado-Joseph disease
• Urine levels of the polyglutamine ataxin-3 protein are elevated in patients with spinocerebellar ataxia type 3
• Vertical pons hyperintensity and hot cross bun sign in cerebellar-type multiple system atrophy and spinocerebellar ataxia type 3
• Which Factors in Spinocerebellar Ataxia Type 3 Patients Are Associated with Restless Legs Syndrome/Willis-Ekbom Disease?